MENU
SGRY
AS OF
Feb 3 closing price
Price
$14.22
Change
-$6.10 (-30.02%)
Capitalization
1.84B
26 days until earnings call
Intraday BUY SELL Signals

SGRY Stock Tickeron detected bearish Stock Pattern: Triangle Symmetrical Bottom SGRY on January 26, 2026, netting in a 4.33% gain over 1 week

A.I.dvisor
at Tickeron.com
Loading...
+4.33% Gain from a Successful pattern Triangle Symmetrical Bottom
SGRY - Surgery Partners
Tickeron
Ticker: SGRY
Company: Surgery Partners
Gain from shorting: +4.33%
Confirmed: 01/26/26
Succeeded: 02/02/26
Total length: 12 days

On January 21, 2026, A.I.dvisor detected a Triangle Symmetrical Bottom Pattern (Bearish) for Surgery Partners (SGRY, $15.47). 5 days later, on January 26, 2026, A.I.dvisor confirmed the Bearish pattern, setting a target price of the stock. On February 02, 2026, the stock hit the target price of $14.24 – resulting in a gain for traders who shorted the stock on the pattern detection date.

SGRY sees MACD Histogram crosses below signal line

SGRY saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on January 28, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 47 instances where the indicator turned negative. In of the 47 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 27, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SGRY as a result. In of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

SGRY moved below its 50-day moving average on January 27, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SGRY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for SGRY entered a downward trend on January 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SGRY advanced for three days, in of 264 cases, the price rose further within the following month. The odds of a continued upward trend are .

SGRY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. SGRY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.064) is normal, around the industry mean (141.598). SGRY's P/E Ratio (2872.000) is considerably higher than the industry average of (116.406). SGRY's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.806). Dividend Yield (0.000) settles around the average of (0.037) among similar stocks. P/S Ratio (0.549) is also within normal values, averaging (2.169).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SGRY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
SGRY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. SGRY showed earnings on November 10, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a company which engages in health care services

Industry HospitalNursingManagement

Profile
Fundamentals
Details
Industry
Hospital Or Nursing Management
Address
340 Seven Springs Way
Phone
+1 615 234-5900
Employees
13500
Web
https://www.surgerypartners.com